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ABSTRACT
Visceral leishmaniasis (VL) or kala-azar, a disseminated infection of the lymphoreticular system of the body, is marked by severe 
defect in immune system of the host. Successful cure of VL depends on the immune status of the host in combination with the 
effects of the antileishmanial drugs. The rationale approach towards eradication of this disease would be to potentiate the immune 
functioning of the host in addition to parasite killing. This review deals with different aspects of adaptive and innate immune 
responses and explores their role in protection or pathogenesis of VL. IL-10 has emerged as the principal cytokine responsible 
for disease pathogenesis, although evidences regarding its source during active VL remain inconclusive. On the other hand, IFNγ, 
under the influence of IL-12, is mostly correlated with healing of the disease. Chemokines are important in mounting cell-mediated 
immune response as they can prevent parasite invasion in association with cytokines. Different types of T cells like CD4, CD8 
and NK T cells also contribute to the immunology of this disease. In spite of conflicting reports, the role of regulatory T cells in 
VL pathogenesis is important. Recently discovered Th17 subset and its different members have been reported to perform diverse 
functions in the course of VL and leishmaniasis as a whole. Innate immune responses, depending on the cell types, are essential 
in early parasite detection and subsequent development of an efficient NK cell response. Immunotherapy targeting IL-10 could 
be looked upon as an interesting option for the treatment of VL.
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INTRODUCTION
Protozoans of the genus Leishmania are obligate intracellular 
parasites causing a broad spectrum of diseases collectively 
known as leishmaniasis. This has emerged as the third most 
prevalent parasite-borne disease worldwide after malaria and 
filariasis1. Manifestations of this disorder can range from less 
severe cutaneous leishmaniasis (CL) characterized by self-
resolving local cutaneous lesions and mucosal leishmaniasis 
(ML) affecting the mucus membranes of mouth, nose and 
throat to the more serious visceral leishmaniasis (VL), which is 
potentially fatal. An estimated 12 million people worldwide have 
some form of leishmaniasis, and another 350 million people are 
at risk. There are approximately 0.5 million new cases of VL 
each year and over 90% of these occur in Brazil, Bangladesh, 
India, Nepal and Sudan, although these numbers are likely to 
be an underestimation since majority of the cases are not even 
reported in these and many of the other 88 endemic countries2. 
VL, caused by Leishmania donovani and Leishmania 
infantum (named Leishmania chagasi in the américas) is 
characterized by persistent low grade fever, hepatosplenomegaly, 
cachexia, pancytopenia and hypergammaglobulinemia. The 
parasite resides primarily within macrophages of the liver, 
spleen, and bone marrow, and the course of the disease indicates 
an underlying defect in immune defense mechanism of the host. 
Earlier reports on Leishmania infection suggested that immune 
response in human CL3,4 and VL were associated with an 
interaction of T helper 1 (Th1)/Th2 cytokines at both cellular5-8 as 
well as transcriptional9 levels and depleted lymphoproliferative 
responses7. This suppressive nature of the immune response 
during active VL was mostly specific to leishmanial antigens 
as tests for delayed-type hypersensitivity (Leishmanin or 
Montenegro tests) to these antigens were negative10. The 
major players of this response were interferon gamma (IFNγ) 
and interleukin-4 (IL-4) in case of both VL and CL. However, 
unlike CL the effects of these cytokines were more of a mixed 
type in case of VL. As the immunological studies progressed 
IL-10 emerged as the most potent factor for VL pathogenesis 
which is evident from recent observations at cellular11, 12 and 
messenger RNA (mRNA) levels13. The scenario, however, 
remains the same for Th1 cytokines as current observations also 
report suppressed antigen specific IFNγ and IL-12 production11,12 
in active VL. The level of IFNγ in serum, however, remains 
high12,14,15, suggesting that their sources could be lymphoid 
organs where the parasite proliferates. Indeed studies confirm 
high IFNγ mRNA expression in bone marrow16, lymph node9 
and splenic13 aspirates. Thus, these studies broadly reaffirm the 
previously described17 interplay of Th1/Th2 cytokines during 
Leishmania infection. Investigation for the cellular specificity of 
these cytokines led to the discovery of the involvement of cluster 
of differentiation 4+ (CD4+), CD8+ and Natural Killer (NK) 
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T cells in this disease. However, as with the earlier reports5,8,18 
more recent observations19-24 also failed to distinguish these T cells 
based on their protective or pathogenic role in VL. Another T cell 
essential for this disease is regulatory T cell (Treg). Although 
the effect of CD4+CD25+ T cells in disease progression has 
already been reported11, the role of CD4+CD25+FoxP3+ natural 
Treg cells in the disease pathology still remains a matter of 
debate13,25,26. Chemokines are important members of cell-
mediated immune response that exhibit antileishmanial activity 
through recruitment of different immune cells at infection sites 
(both liver and spleen). In leishmaniasis, both cytokines and 
chemokines interact closely to strengthen the host defense 
against parasite. IL-17, the signature cytokine for the recently 
discovered Th17 subset, was found to play a significant role 
in the migration, recruitment and activation of neutrophils. 
Since the neutrophils are known to have important regulatory 
and/or effector functions during Leishmania infection, Th17 
can be looked upon as an important regulator for this disease. 
Indeed, there have been reports of involvement of different 
Th17 cytokines like IL-17, IL-2227 and IL-2128 in human VL. In 
addition to adaptive immune response innate immune response 
involving cells like dendritic cells (DCs), macrophages, 
neutrophil/eosinophil etc. are essential in regulating the initial 
entry of parasites. They are involved not only in preventing 
parasite invasion but also in controlling their multiplication 
through the release of different cytokines. This review will 
examine the interplay of different components of adaptive and 
innate immune responses and their involvement in disease or 
elimination of human VL.
DIFFERENT CYTOKINES, CHEMOKINES AND 
CELLULAR SUBSETS: ROLE IN VL
A close look at the progressive findings in the field of 
immunology of human VL suggests important roles of different 
cytokines in disease protection and pathogenesis. Few of 
the very first reports on VL immunopathogenesis regarded 
upregulation of IL-48,17 and IL-105 and loss of function of 
IFNγ5-7,9 as the indication of active disease. In fact IL-4 was 
initially regarded as a marker for active disease8. However, 
later observations exhibited its mixed response towards VL. 
Whereas some reports indicated lower IL-4 levels in nodal and 
portal areas of in situ liver lesions as well as in serum during 
disease14 and its corresponding enhancement after cure19, others 
suggested enhancement of IL-4+ neutrophils in active VL29. As 
more investigations were carried out using different samples like 
tissue sections20, plasma14,15,18,19,30-33, whole blood34, peripheral 
blood mononuclear cells (PBMC)11,12,31,35,36, mRNA35-37 and 
splenic aspirate cells38 more evidences emerged suggesting 
IL-10 to be the principal contributor for VL pathology. Results 
from flow cytometric studies of cytokines also supported this 
finding18,29. Post kala-azar dermal leishmaniasis (PKDL), a 
disease manifestation of VL, is also characterized by enhanced 
IL-414,39 as well as IL-10 expression and perhaps the subsequent 
masking effect exerted on IFNγ by IL-10 is apparent from a 
generally heightened response of this cytokine9,11,14,39-41. Like 
IFNγ, IL-12 is also responsible for a protective response. In 
fact it influences the production of IFNγ6,7,11,12,20,33 and the loss 
of lymphoproliferative response during active VL was formerly 
attributed to its lower expression6,7. As already mentioned 
this loss of lymphoproliferation could be looked upon as a 
failure of response towards Leishmania antigen and it has 
been proposed that PBMCs of VL patients might consist of 
a non-Leishmania antigen-specific population which fails to 
proliferate upon Leishmania antigen stimulation10. Although 
primarily protective, IFNγ could sometimes be associated 
with disease exacerbating conditions as was evident in an 
alternate activation pathway of Th1 cells through Trp-Ser-X-1 
(WSX-1) ligation which might also lead to activation of 
transcription factor for IL-1042. 
The mechanism of the suppressive activity of IL-10 in 
human VL was primarily attributed to reduction in migration 
inhibitory factor (MIF) regulated accumulation of monocyte-
derived macrophages43 and inhibition of NO generation from 
macrophages resulting in downregulation of leishmanicidal 
activity44. Recently more insights have come up regarding 
IL-10 expression and regulation where its production from 
macrophages infected with L. donovani is reported to be 
negatively influenced by glycogen synthase kinase-3β 
(GSK-3β). GSK-3β expression, on the other hand, is inhibited 
by either phosphatidylinositol-3 kinase (PI3K) or activated form 
of serine-threonine kinase Akt36. Another interesting observation 
has suggested that intracellular network of PI3K along with 
mammalian target of rapamycin (mTOR) signaling pathway 
regulate IL-10 modulation by L. donovani45.
IFNγ and IL-10 might be the major players of VL pathology, 
but various other cytokines also have significant role in disease 
persistence. Some of them are traditionally known whereas others 
have emerged through progressive research. One such member, 
IL-6, was known to be associated with both active VL14,18,46 and 
PKDL14 conditions. It is an important pro-inflammatory cytokine 
related to Th2 differentiation47, inflammation and Th1 response48 
as well as development of Th17 cells49. Thus IL-6 maintains 
a balance between T cell responses during active disease. 
Involvement of transforming growth factor beta (TGFβ) in 
VL pathology was earlier reported by Saha et al.11, which later 
on got confirmed by immunohistochemical observation of 
Kupffer cells50 and polymorphism study of a particular locus 
of TGB1 gene51. Mechanism of action of TGFβ, in active 
L. donovani infection, was thought to be associated with 
overexpression of ubiquitin-editing enzyme A20 through 
tyrosine phosphatase response ensuring transient activation of 
inflammatory signaling pathways in macrophages52. It was also 
known to contribute towards PKDL manifestation11,14.
Another important cytokine tumor necrosis factor alpha 
(TNFα), known for exerting cytotoxic effects on invading 
pathogens, along with its receptor TNFR is also closely 
associated with VL pathogenesis and PKDL manifestation. 
This was previously reported by Medeiros et al.53 and further 
supported by more recent observations18,32,38,41,46,54-57 in both VL 
and PKDL patients.  Unique cytokines have also emerged in 
implicating disease progression as recent observations indicate 
IL-27 to be the regulator of IL-10 producing T cells through 
induction of IL-2128.   
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Chemokines, which are chemotactic cytokines, also 
play crucial roles during Leishmania infection. They help in 
eliciting antileishmanial activity by promoting cell-mediated 
immune response through recruitment of different subsets of 
leukocytes at infection site and subsequently stimulating them. 
Members of the chemokine family involved in this process 
depend on the stage of infection and pathogens involved; the 
cell populations recruited at the early stage are essential in 
defining the outcome of the disease58. In one study elevated 
levels of chemokines, chemokine (C-X-C motif) ligand 
9 [CXCL9] and CXCL10, were reported in serum during active 
infection and it was suggested that these chemokines along 
with IFNγ play an important immunopathogenic role during 
disese30. Since not many reports are available regarding the 
role of chemokines in human VL we will mainly discuss the 
importance of different chemokines in experimental VL models 
where they are known to mount a Th1 response through their 
influence on IFNγ production. Indeed L. donovani infected mice 
lacking chemokine receptor chemokine (C-C motif) receptor 
5 [CCR5] or its ligand macrophage inflammatory protein (MIP) 
1α exhibits a low antigen-specific IFNγ production during the 
initial phases of infection59. The higher expression of MIP-1α 
along with chemokine (C-C motif) ligand 2 [CCL2] in liver cells 
of L. donovani infected mice during early stages of infection is 
responsible for the recruitment of monocytes. Monocytes thus 
recruited could produce Th1 mobilizing chemokine CXCL10 
under the influence of IFNγ at the late phase of infection enabling 
hepatic granuloma formation and lymphocyte recruitment60. 
L. donovani infection could also downregulate CCR7 
expression, thereby impairing DC migration to draining lymph 
nodes and facilitating disease progression61. The scenario is 
somewhat different in spleen cells of L. infantum infected mice 
where Th2 type response predominates over Th1. This response 
is regulated by persistent CCL2 expression suggesting that there 
is an invasion of macrophages rather than T cells in the spleen62. 
Investigations are also being carried out to determine the 
source of these various cytokines so that particular cell types 
could be attributed to VL infection. Previously CD4+8 and 
CD8+ 5,63 T cell populations were reported to be major contributors 
of disease manifestation. They still remain so, however, further 
observations identify different CD4 sub-populations like 
chemokine receptor-5 (CCR5)+CD4+64 and CD2lowCD4+65 to 
be the markers of active VL. Human immunodeficiency virus 
(HIV) co-infection has emerged as a potent threat in VL patients 
and their involvement with different T cells is established with 
reports of higher CXCR4, a co-receptor of HIV, expression on 
CD4+T cells66 and lower CD8+ T cell count67 in patients with 
HIV-VL. Subpopulations of CD8+ T cells also become important 
as lower expression of bone-marrow CD8+CD18+CD45RO+ 
lymphocytes can be looked upon as the biomarker of acute VL68. 
NK T cells (CD3+CD161+Va24-), formerly known for clearance 
of parasite from liver by direct and indirect lysis54 and playing 
a regulatory role in VL69, are also reported to produce IFNγ in 
response to L. donovani antigens at the disease site70.
Further exploration of the cellular origin of cytokines led 
to the discovery of a distinct T cell subset known as regulatory 
T cells (Treg).   Elemental role of Treg cells include homeostasis 
and prevention of excessive inflammation mostly due to IL-10 
production71. These can be broadly divided into two categories: 
thymus derived CD4+CD25+FoxP3+ natural Treg (nTreg) cells, 
and inducible Tregs that are derived from periphery and are 
either FoxP3+ (iTreg) or adaptive FoxP3- type-I Treg cells (Tr1). 
There are contradictory reports regarding the role of nTregs 
in VL progression. Whereas some observations downplayed 
the importance of nTregs as the population responsible for 
IL-10 secretion and disease pathogenesis13,26, others suggested 
it to be the source of IL-1025. Role of CD4+CD25+ T cells 
in PKDL pathogenesis was reported by Saha et al.11 This 
observation was further extended in reports of enhanced 
lesional CD4+CD25+FoxP3+ expression in PKDL patients23. 
More conclusive evidences came from the demonstration of 
accumulated nTreg cells at infection site with a correlation of 
both IL-10 and nTreg levels with parasite burden, thus implying 
their role in disease severity in PKDL72.
TH17 CELLS: SIGNIFICANCE IN PROTECTION  
AND PROGRESSION OF LEISHMANIASIS
Th17 subset of T cells was only identified in 2005 and 
mainly associated with different autoimmune diseases like 
psoriasis, multiple sclerosis (MS), rheumatoid arthritis (RA) and 
inflammatory bowel disease (IBD) as well as allergic reactions 
including asthma73. Th17 cell lineage development is induced by 
cytokines such as IL-6, IL-23 and TGFβ49 which in turn activate 
the signal transducer and activator of transcription (STAT)3 
pathway74 leading to the expression of the transcription factor 
retinoic-acid orphan related receptors (ROR-α and ROR-γt)71. 
Th17 cells mainly produce IL-17A and IL-17F cytokines, in 
addition to other cytokines such as IL-21 and IL-2275. IL-17 
performs an important function in neutrophil development 
and since neutrophils are regarded as an important effector 
during Leishmania infection, it would be possible that Th17 
cells might have a significant role in this disease76. However, 
the exact function they perform in this disease depends largely 
on the parasite species and the genetic background of the host.
First report of the involvement of Th17 subset in human 
VL came from studies of Pitta et al.27 when they suggested that 
IL-17 and IL-22, along with Th1 cytokines, play complementary 
roles in protective response against VL and any defect in 
this mechanism could increase the risk of this disease. More 
recent observations, however, indicate IL-21 to be the part of a 
feedback control mechanism that could lead to the expansion 
of IL-10-producing T cells thereby representing its role as a 
disease-promoting cytokine28. Increased lesional expression 
of IL-17 and IL-23 in PKDL patients and their subsequent 
downregulation following cure establish the importance of Th17 
cells in this disease41.   
Since not many reports are available regarding the 
involvement of Th17 cells in human VL, we will include 
experimental VL as well as other forms of leishmaniasis in our 
discussion. Disease promoting role of IL-17 has been recognized 
in IL-17 deficient mice model of CL which show lesser infection 
severity than IL-17 positive mice. This effect was attributed 
mainly to IL-17 because comparable levels of other cytokines 
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like IL-10, IFNγ etc. was observed in both IL-17 positive and 
depleted mice whereas reduced neutrophil recruitment was 
reported only in IL-17 deficient mice77, thereby establishing 
the association between increased neutrophil recruitment and 
severity of disease.
Conflicting roles of IL-17 in disease pathology was also 
evident in other Leishmania species. Whereas studies with 
experimental models of L. braziliensis78 and L. panamensis79 
infections exhibited induction of healing in association with 
elevated IL-17 as well as IFNγ levels, reports from human ML 
suggested that IL-17 was involved in ML pathogenesis80.
Vaccine studies provide evidence for the protective 
role of Th17 cells as live L. major plus CpG DNA vaccine 
led to enhanced proliferation of CD4+ Th17 cells thereby 
preventing lesion development and providing long-term 
immunity43. Similar observations were made in experimental VL 
where protection induced by CpG stimulated bone marrow-
derived DCs pulsed with L. infantum kinetoplastid membrane 
protein 11 (KMP-11) peptide was correlated with secretion 
of IL-1781. 
IL-27 is known to be an important regulator of the expression 
of Th17 cell lineage. It belongs to the IL-6/IL-12 cytokine 
family and its suppressive effect on Th17 subset was earlier 
reported in experimental autoimmune encephalomyelitis82 
and murine influenza infection83. This observation was further 
extended in murine CL model where IL-27 was found to 
maintain a critical balance between disease protection and 
pathogenesis by inducing IFNγ and IL-10 from CD4+ T cells 
and suppressing inappropriate Th17 development84. Interesting 
observations regarding IL-27/T-cell cytokine receptor (TCCR) 
pathway has been made for experimental VL where, unlike CL, 
disease resistance was linked to IL-27/TCCR-/- rather than their 
wild-type counterparts85. However, these results were attributed 
to liver immunopathology and no Th17 component was 
examined.
INNATE IMMUNE RESPONSE
Innate immune response against Leishmania infection plays 
a pivotal role in predicting the outcome of the disease. It not only 
helps in preventing the early parasite growth and spreading of 
infection but also acts as a source of different immunoregulatory 
cytokines. Leishmania being an opportunistic parasite can 
employ several strategies for its survival inside the macrophage 
phagolysosomes. Macrophage, one of the major players of 
innate immunity, was primarily known to exert its effects against 
L. donovani infection through the production of inducible 
nitric oxide synthase (iNOS) in liver86. Although one report 
suggested the anti-parasitic effect of macrophages in liver to 
be iNOS-independent87, the mechanism by which it exerts its 
antileishmanial activity remained mostly iNOS-dependent in 
both liver and spleen88, 89. Studies are, in fact, being carried out 
to discover the iNOS-independent parasiticidal mechanism of 
macrophages. Leishmania donovani, on the other hand, is known 
to evade the iNOS-dependent killing in macrophages through 
the induction of arginase 1 in an IL-10 mediated fashion90. 
DCs, another important contributor of the innate response, can 
be of two types- myeloid (mDC) and plasmacytoid (pDC). Of 
these mDCs are known to exert cytotoxic effects on L. infantum 
parasites by producing IL-12 under the influence of Toll-like 
receptor (TLR) 9 and inducing NK cells to release IFNγ91. 
pDCs, however, are unable to phagocytose parasites, but they 
can produce IL-12 in a TLR-9 dependent manner suggesting 
their relevance during later stages of infection91. Studies in VL 
patients suggested a reduced secretory activity of neutrophils 
and eosinophils attributable to the deficiencies in the production 
of their potent activators IL-8 and eotaxin, respectively92. 
Cytokines secreted by these cells during infection show a 
predominant Th2 response with an enhanced IL-4+ neutrophil 
and IL-10+ eosinophil and reduced IFNγ+ and IL-12+ eosinophil 
frequencies29 (Figure 1).
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FIGURE 1 - Interaction of different components of innate and adaptive immune systems 
and their possible role in parasite persistence/clearance.  
Rapid hepatic accumulation of chemokines CCL2, CXCL9, CXCL10 that occurs after 
infection leads to a Th1 response through IFNγ and facilitates parasite clearance by 
macrophages.  By contrast, in the spleen, a consistent expression of CCL2 leads to 
a dominance of Th2 cytokines and sustained parasite persistence. IL-12 produced by 
mDCs could activate NK cells to secrete IFNγ. IL-10 produced by Treg is the key factor 
for disease pathogenesis.  IL-27, produced by macrophages, can suppress Th17 subset. 
It could also activate Treg cells in collaboration with IL-21 produced by CD4 T cells. 
KPF: Kupffer cells; SPL: spleen; M: monocyte; MIP-1α: macrophage inflammatory protein-
1alpha; CCL: chemokine (C-C motif) ligand; CXCL: chemokine (C-X-C motif) ligand; 
CD: cluster of differentiation; IL: interleukin; Th: T helper; mDC: myeloid dendritic cell; 
NK: natural killer; Mϕ: macrophage; iNOS: inducible nitric oxide synthase; Treg: regulatory 
T cell; IFNγ: interferon gamma; TGFβ: transforming growth factor beta.
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